Portuguese 
English 
Spanish 
3 min of reading 
0 comments 
Bayer Announces Global Job Cuts Amid Restructuring and Billion-Dollar Lawsuits Over Alleged Cancer Risk
According to information from FDR and official data from the company itself, the pharmaceutical industry giant Bayer confirmed on Wednesday (6) the layoff of approximately 12,000 employees worldwide. This measure is part of a global restructuring plan aimed at accelerating internal decisions and reducing administrative and managerial positions.
The German multinational, which ended June 2024 with around 90,000 employees, is facing one of the most delicate moments in its recent history. In addition to the pressure to improve efficiency and competitiveness, the company is also dealing with high-profile litigation involving the herbicide Roundup, accused of causing cancer in consumers and workers.
What Is Behind the Layoffs
According to Bayer’s statement, the decision to cut jobs is linked to the need to simplify its structure and make operations more agile. The goal is to eliminate layers of management that, according to the company, hinder quick responses to market changes.
-
Brazilian city bets on the business environment to generate jobs and attract investments in the energy sector — secretary reveals strategy at Macaé Energy 2026.
-
50 viaducts, 4 tunnels, 28 bridges, and 40 kilometers of bike paths: BR-262 in Espírito Santo will receive 8.6 billion reais for the largest engineering project in the state’s history, inspired by the Immigrant Highway in São Paulo.
-
Brazil produces too much clean energy and doesn’t know what to do with it: over 20% of solar and wind capacity was wasted in 2025 while investors flee and 509 renewable generation projects were abandoned in the last year.
-
Piauí will produce a new fuel that replaces diesel without needing to change anything in the truck’s engine and reduces pollutant gas emissions by half: truck drivers from all over the Northeast are already celebrating the news that will arrive later this decade.
The reduction in the payroll occurs amid a backdrop of financial challenges, high competition, and pressure for results from investors. The move is also seen as part of a strategy to reposition Bayer in an increasingly demanding global environment.
The Roundup Case and the Weight of Lawsuits
The herbicide Roundup is at the epicenter of thousands of lawsuits in the United States. The product, widely used in agriculture, has been accused of causing cancer, resulting in damage to Bayer’s reputation and high legal costs.
To deal with potential indemnities, the company has already allocated US$ 7.4 billion and announced another 1.2 billion euros (about US$ 1.37 billion) for additional legal expenses. These amounts directly impact the financial health of the pharmaceutical giant, increasing the pressure for internal changes.
Pressure from Investors and Possible Structural Changes
The pharmaceutical industry giant is also facing pressure to sell part of its operations, including the consumer health division, or even to spin off its agricultural unit. Despite speculation, Bayer claims there are no concrete plans for divestiture or asset sales at this time.
Nevertheless, experts point out that the company needs to adopt efficiency measures and adapt to maintain relevance in the global market, considering the fierce competition and high legal costs it is facing.
A Future of Uncertainties
With over 150 years of activity, Bayer has built a solid reputation in the pharmaceutical and agricultural sectors, but is now facing a turbulent period. The success of the restructuring will depend on its ability to balance cost-cutting with investments in innovation and crisis management.
The combination of mass layoffs, billion-dollar lawsuits, and strategic changes places the company in a decisive moment — and the market will closely monitor every step taken.
And you, do you believe that the restructuring and the layoff of 12,000 employees will be enough to stabilize the pharmaceutical industry giant, or will the impact of the cancer accusations be irreversible? Leave your opinion in the comments — we want to hear from those who closely follow the sector.
Seja o primeiro a reagir!